Connection

Ulrich Laufs to Mineralocorticoid Receptor Antagonists

This is a "connection" page, showing publications Ulrich Laufs has written about Mineralocorticoid Receptor Antagonists.
  1. The non-steroidal mineralocorticoid receptor antagonist finerenone prevents cardiac fibrotic remodeling. Biochem Pharmacol. 2019 10; 168:173-183.
    View in: PubMed
    Score: 0.683
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.